ALLO vs OMC · rev $22.0K vs rev $17.27B
Allogene Therapeutics Inc (ALLO) versus Omnicom Group Inc (OMC) — a side-by-side from cached financials, not a winner call.
Allogene Therapeutics Inc (ALLO) is a biotechnology company listed on US.
Omnicom Group Inc (OMC) is a advertising agencies company listed on NYSE.
Latest reported ALLO revenue for 2024-12-31 was $22.0K. Net income was -$257.6M. Revenue was down 76.8% from 2023-12-31 to 2024-12-31. ALLO currently screens at market cap $258.1M.
Latest reported OMC revenue for 2025-12-31 was $17.27B. Net income was -$54.5M. Revenue was up 10.1% from 2024-12-31 to 2025-12-31. OMC currently screens at market cap $21.75B.
ALLO currently screens at market cap $258.1M. OMC currently screens at market cap $21.75B.
Not investment advice. Open the ALLO and OMC stock pages for the full models.
Not investment advice.